Carrie Richardson

541 total citations
21 papers, 348 citations indexed

About

Carrie Richardson is a scholar working on Pathology and Forensic Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Carrie Richardson has authored 21 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Epidemiology and 8 papers in Rheumatology. Recurrent topics in Carrie Richardson's work include Systemic Sclerosis and Related Diseases (9 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Heterotopic Ossification and Related Conditions (3 papers). Carrie Richardson is often cited by papers focused on Systemic Sclerosis and Related Diseases (9 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Heterotopic Ossification and Related Conditions (3 papers). Carrie Richardson collaborates with scholars based in United States, United Kingdom and Canada. Carrie Richardson's co-authors include Ami A. Shah, Livia Casciola‐Rosen, Antony Rosen, Anna Plaas, Fredrick M. Wigley, Takeru Igusa, Laura K. Hummers, Kala Visvanathan, Jungwha Lee and Rowland W. Chang and has published in prestigious journals such as Annals of the Rheumatic Diseases, American Journal of Physiology-Heart and Circulatory Physiology and Fertility and Sterility.

In The Last Decade

Carrie Richardson

20 papers receiving 346 citations

Peers

Carrie Richardson
Carrie Richardson
Citations per year, relative to Carrie Richardson Carrie Richardson (= 1×) peers Daniel Sánchez‐Cano

Countries citing papers authored by Carrie Richardson

Since Specialization
Citations

This map shows the geographic impact of Carrie Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie Richardson more than expected).

Fields of papers citing papers by Carrie Richardson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie Richardson. The network helps show where Carrie Richardson may publish in the future.

Co-authorship network of co-authors of Carrie Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie Richardson. A scholar is included among the top collaborators of Carrie Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie Richardson. Carrie Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Carrie, et al.. (2025). Intracardiac Echo Versus Fluoroscopic Guidance for Pulsed Field Ablation: Single-Center Real-Life Study. Biomedicines. 13(5). 1186–1186.
2.
Patel, Prem, et al.. (2024). Outcomes of NSTEMI Admissions and Significance of TIMI Scores: A Nationwide Analysis Using the National Inpatient Sample. Journal of Clinical Medicine. 14(1). 171–171. 1 indexed citations
3.
Roberts, Mark, et al.. (2023). What is the impact of a Hepatitis C ‘test, trace and treat’ pilot using peer workers?. Journal of Viral Hepatitis. 30(12). 922–925. 2 indexed citations
4.
Richardson, Carrie, Jamie Perin, Scott L. Zeger, et al.. (2022). Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis. Lara D. Veeken. 62(11). 3636–3643. 7 indexed citations
5.
Mecoli, Christopher A., Takeru Igusa, Jemima Albayda, et al.. (2022). Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population. Arthritis & Rheumatology. 75(4). 620–629. 21 indexed citations
6.
Frech, Tracy, Shervin Assassi, Jessica Gordon, et al.. (2022). The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation. Clinical and Experimental Rheumatology. 41(8). 1632–1638. 1 indexed citations
7.
Chung, Melody P., Christopher A. Mecoli, Jamie Perin, Carrie Richardson, & Zsuzsanna H. McMahan. (2022). Perifollicular Hypopigmentation in Systemic Sclerosis: Associations With Clinical Features and Internal Organ Involvement. The Journal of Rheumatology. 49(5). 475–481. 2 indexed citations
8.
Richardson, Carrie, David Aaby, Jungwha Lee, et al.. (2021). Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis. The Journal of Rheumatology. 48(12). 1830–1838. 7 indexed citations
9.
Richardson, Carrie, Anna Plaas, & John Varga. (2020). Calcinosis in Systemic Sclerosis: Updates in Pathophysiology, Evaluation, and Treatment. Current Rheumatology Reports. 22(10). 73–73. 15 indexed citations
10.
Chung, Melody P., Carrie Richardson, David Kirakossian, et al.. (2020). Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis. Autoimmunity Reviews. 19(6). 102533–102533. 37 indexed citations
11.
Richardson, Carrie, Anna Plaas, & Joel A. Block. (2019). Intra-articular Hyaluronan Therapy for Symptomatic Knee Osteoarthritis. Rheumatic Disease Clinics of North America. 45(3). 439–451. 21 indexed citations
12.
Igusa, Takeru, Laura K. Hummers, Kala Visvanathan, et al.. (2018). Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer. Annals of the Rheumatic Diseases. 77(8). 1179–1186. 78 indexed citations
13.
Aaby, David, Jungwha Lee, Carrie Richardson, et al.. (2018). Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis. The Journal of Rheumatology. 45(11). 1572–1576. 36 indexed citations
14.
Poornima, Indu, Kelly J. Shields, Lewis H. Kuller, et al.. (2018). Associations of osteoprotegerin with coronary artery calcification among women with systemic lupus erythematosus and healthy controls. Lupus. 27(6). 880–889. 5 indexed citations
15.
Richardson, Carrie & Uzma Haque. (2018). Pulmonary Capillaritis in a Patient With Antisynthetase Syndrome and Anti–PL-7 Antibodies. JCR Journal of Clinical Rheumatology. 25(6). e91–e92. 3 indexed citations
16.
Richardson, Carrie, Rishi Agrawal, Jungwha Lee, et al.. (2016). Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study. Seminars in Arthritis and Rheumatism. 46(1). 109–114. 49 indexed citations
17.
Ramsey‐Goldman, Rosalind, Carrie Richardson, Moro O. Salifu, et al.. (2016). Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients. Lupus Science & Medicine. 3(1). e000156–e000156. 10 indexed citations
18.
Yin, Ping, Antònia Navarro, Feng Fang, et al.. (2011). Early growth response-2 expression in uterine leiomyoma cells: regulation and function. Fertility and Sterility. 96(2). 439–444. 10 indexed citations
19.
Richardson, Carrie, et al.. (2008). Demonstration of a Pilot-Scale Membrane Reactor Process for Hydrogen Production. ECS Transactions. 12(1). 499–510. 5 indexed citations
20.
Cavet, Jim, Anne Lennard, A. Gascoigne, et al.. (2000). Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplantation. 25(5). 571–573. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026